Acupuncture Synergized With Bortezomib Improves Survival of Multiple Myeloma Mice via Decreasing Metabolic Ornithine.
Acupuncture Synergized With Bortezomib Improves Survival of Multiple Myeloma Mice via Decreasing Metabolic Ornithine.
复制标题
DOI：
10.3389/fonc.2021.779562
复制
发表时间：
2021
影响因子：
4.7
通讯作者：
Yang Y
中科院分区：
文献类型：
--
作者：
Ke M;Qian J;Hao F;Li X;Wu H;Luo X;Xu B;Gu C;Yang Y
Multiple myeloma (MM) is a hematological malignancy worldwide in urgent need for novel therapeutic strategies. Since Velcade (bortezomib) was approved for the treatment of relapsed/refractory MM in 2003, we have seen considerable improvement in extending MM patient survival. However, most patients are fraught with high recurrence rate and incurability. Acupuncture is known for alleviating patient symptoms and improving the quality of life, but it is not well investigated in MM, especially in combination with bortezomib. In this study, we employed LC-MS and UHPLC-MS together with bioinformatics methods to test serum samples from 5TMM3VT MM murine model mice with four different treatments [control (C) group, bortezomib (V) treatment group, acupuncture (A) group, and combined (VA) group]. MM mice in group VA had longer survival time than mice in group A or group V. Joint pathway analysis indicated the underlying arginine and proline metabolism pathway among the 32 significantly decreased metabolites in group VA. CCK-8 assay and in vivo experiments validated that ornithine, the metabolite of arginine, promoted MM cell proliferation. In addition, gene expression omnibus (GEO) database analysis suggested that MM patients with higher ornithine decarboxylase 1 (ODC1) expression were evidently associated with poor overall survival. In summary, this study demonstrates the synergistic effects of acupuncture and bortezomib on extending the survival of MM model mice and provides potential therapeutic targets in the treatment of MM.
登录
查看更多内容
影响因子：
2.9
作者：
Bao T;Goloubeva O;Pelser C;Porter N;Primrose J;Hester L;Sadowska M;Lapidus R;Medeiros M;Lao L;Dorsey SG;Badros AZ
通讯作者：
Badros AZ
影响因子：
5.5
作者：
Du T;Han J
通讯作者：
Han J
影响因子：
7.9
作者：
He W;Roh E;Yao K;Liu K;Meng X;Liu F;Wang P;Bode AM;Dong Z
通讯作者：
Dong Z
针刺联合甲钴胺治疗多发性骨髓瘤化疗所致周围神经病变
影响因子：
3.8
作者：
Han X;Wang L;Shi H;Zheng G;He J;Wu W;Shi J;Wei G;Zheng W;Sun J;Huang H;Cai Z
通讯作者：
Cai Z
鸟氨酸脱羧酶基因启动子中的G316a多态性调节了MYCN驱动的儿童神经母细胞瘤。
影响因子：
5.2
作者：
Gamble LD;Purgato S;Henderson MJ;Di Giacomo S;Russell AJ;Pigini P;Murray J;Valli E;Milazzo G;Giorgi FM;Cowley M;Ashton LJ;Bhalshankar J;Schleiermacher G;Rihani A;Van Maerken T;Vandesompele J;Speleman F;Versteeg R;Koster J;Eggert A;Noguera R;Stallings RL;Tonini GP;Fong K;Vaksman Z;Diskin SJ;Maris JM;London WB;Marshall GM;Ziegler DS;Hogarty MD;Perini G;Norris MD;Haber M
通讯作者：
Haber M